Literature DB >> 29348253

Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling.

Louis J Dell'Italia1, James F Collawn2, Carlos M Ferrario2.   

Abstract

Chymase is the most efficient Ang II (angiotensin II)-forming enzyme in the human body and has been implicated in a wide variety of human diseases that also implicate its many other protease actions. Largely thought to be the product of mast cells, the identification of other cellular sources including cardiac fibroblasts and vascular endothelial cells demonstrates a more widely dispersed production and distribution system in various tissues. Furthermore, newly emerging evidence for its intracellular presence in cardiomyocytes and smooth muscle cells opens an entirely new compartment of chymase-mediated actions that were previously thought to be limited to the extracellular space. This review illustrates how these multiple chymase-mediated mechanisms of action can explain the residual risk in clinical trials of cardiovascular disease using conventional renin-angiotensin system blockade.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  angiotensin II; chymases; endothelial cells; mast cells; renin

Mesh:

Substances:

Year:  2018        PMID: 29348253      PMCID: PMC5776735          DOI: 10.1161/CIRCRESAHA.117.310978

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  251 in total

1.  Dipeptidyl peptidase I cleaves matrix-associated proteins and is expressed mainly by mast cells in normal dog airways.

Authors:  P J Wolters; M Laig-Webster; G H Caughey
Journal:  Am J Respir Cell Mol Biol       Date:  2000-02       Impact factor: 6.914

2.  Differential regulation of angiotensin-(1-12) in plasma and cardiac tissue in response to bilateral nephrectomy.

Authors:  Carlos M Ferrario; Jasmina Varagic; Javad Habibi; Sayaka Nagata; Johji Kato; Mark C Chappell; Aaron J Trask; Kazuo Kitamura; Adam Whaley-Connell; James R Sowers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-13       Impact factor: 4.733

Review 3.  Mast cell peptidases: chameleons of innate immunity and host defense.

Authors:  Neil N Trivedi; George H Caughey
Journal:  Am J Respir Cell Mol Biol       Date:  2009-11-20       Impact factor: 6.914

4.  IGF-1 degradation by mouse mast cell protease 4 promotes cell death and adverse cardiac remodeling days after a myocardial infarction.

Authors:  Thor Tejada; Lin Tan; Rebecca A Torres; John W Calvert; Jonathan P Lambert; Madiha Zaidi; Murtaza Husain; Maria D Berce; Hussain Naib; Gunnar Pejler; Magnus Abrink; Robert M Graham; David J Lefer; Nawazish Naqvi; Ahsan Husain
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-06       Impact factor: 11.205

5.  Intracellular angiotensin II activates rat myometrium.

Authors:  Elena Deliu; Andrei A Tica; Dana Motoc; G Cristina Brailoiu; Eugen Brailoiu
Journal:  Am J Physiol Cell Physiol       Date:  2011-05-25       Impact factor: 4.249

6.  The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage I non-small cell lung cancer.

Authors:  Toshihiko Ibaraki; Michiko Muramatsu; Shinji Takai; Denan Jin; Hiroshi Maruyama; Tatsuhiko Orino; Takahiro Katsumata; Mizuo Miyazaki
Journal:  Eur J Cardiothorac Surg       Date:  2005-10       Impact factor: 4.191

7.  Impact of chymase inhibitor on cardiac function and survival after myocardial infarction.

Authors:  Denan Jin; Shinji Takai; Mayumi Yamada; Masato Sakaguchi; Keiichi Kamoshita; Koichi Ishida; Yoshikazu Sukenaga; Mizuo Miyazaki
Journal:  Cardiovasc Res       Date:  2003-11-01       Impact factor: 10.787

8.  Mast cell chymase protects against renal fibrosis in murine unilateral ureteral obstruction.

Authors:  Walid Beghdadi; Lydia C Madjene; Julien Claver; Gunnar Pejler; Lucie Beaudoin; Agnès Lehuen; Eric Daugas; Ulrich Blank
Journal:  Kidney Int       Date:  2013-03-20       Impact factor: 10.612

Review 9.  Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.

Authors:  Franck F Rahaghi; Marc Miravitlles
Journal:  Respir Res       Date:  2017-05-30

10.  The chymase, mouse mast cell protease 4, constitutes the major chymotrypsin-like activity in peritoneum and ear tissue. A role for mouse mast cell protease 4 in thrombin regulation and fibronectin turnover.

Authors:  Elena Tchougounova; Gunnar Pejler; Magnus Abrink
Journal:  J Exp Med       Date:  2003-08-04       Impact factor: 14.307

View more
  32 in total

1.  Photostable and Proteolysis-Resistant Förster Resonance Energy Transfer-Based Calcium Biosensor.

Authors:  Dat Nguyen; Danielle M Behrens; Sanjana Sen; Avid Najdahmadi; Jessica N Pham; Gaetano Speciale; Micah M Lawrence; Sudipta Majumdar; Gregory A Weiss; Elliot L Botvinick
Journal:  Anal Chem       Date:  2020-05-13       Impact factor: 6.986

2.  Differential Expression of the Angiotensin-(1-12)/Chymase Axis in Human Atrial Tissue.

Authors:  Hao Wang; Jasmina Varagic; Sayaka Nagata; Neal D Kon; Sarfaraz Ahmad; Jessica L VonCannon; Kendra N Wright; Xuming Sun; Dwight Deal; Leanne Groban; Carlos M Ferrario
Journal:  J Surg Res       Date:  2020-04-30       Impact factor: 2.192

Review 3.  Mast cell chymase: morphofunctional characteristics.

Authors:  Dmitri Atiakshin; Igor Buchwalow; Markus Tiemann
Journal:  Histochem Cell Biol       Date:  2019-08-08       Impact factor: 4.304

4.  Noncanonical Mechanisms for Direct Bone Marrow Generating Ang II (Angiotensin II) Predominate in CD68 Positive Myeloid Lineage Cells.

Authors:  Tomohisa Yamashita; Sarfaraz Ahmad; Kendra N Wright; Drew J Roberts; Jessica L VonCannon; Hao Wang; Leanne Groban; Louis J Dell'Italia; Carlos M Ferrario
Journal:  Hypertension       Date:  2019-12-09       Impact factor: 10.190

Review 5.  Chymase inhibitors for the treatment of cardiac diseases: a patent review (2010-2018).

Authors:  Sarfaraz Ahmad; Carlos M Ferrario
Journal:  Expert Opin Ther Pat       Date:  2018-10-10       Impact factor: 6.674

Review 6.  Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges.

Authors:  Krishna Sriram; Rohit Loomba; Paul A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-17       Impact factor: 11.205

Review 7.  Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System: Pressing Needs and Best Research Practices.

Authors:  Matthew A Sparks; Andrew M South; Andrew D Badley; Carissa M Baker-Smith; Daniel Batlle; Biykem Bozkurt; Roberto Cattaneo; Steven D Crowley; Louis J Dell'Italia; Andria L Ford; Kathy Griendling; Susan B Gurley; Scott E Kasner; Joseph A Murray; Karl A Nath; Marc A Pfeffer; Janani Rangaswami; W Robert Taylor; Vesna D Garovic
Journal:  Hypertension       Date:  2020-09-28       Impact factor: 10.190

Review 8.  Anaphylactic cardiovascular collapse and Kounis syndrome: systemic vasodilation or coronary vasoconstriction?

Authors:  Nicholas G Kounis; Gianfranco Cervellin; Ioanna Koniari; Laura Bonfanti; Periklis Dousdampanis; Nikolaos Charokopos; Stelios F Assimakopoulos; Stavros K Kakkos; Ioannis G Ntouvas; George D Soufras; Ioannis Tsolakis
Journal:  Ann Transl Med       Date:  2018-09

9.  Estrogen modulates the differential expression of cardiac myocyte chymase isoforms and diastolic function.

Authors:  Hao Wang; Xuming Sun; Sarfaraz Ahmad; Jing Su; Carlos Maria Ferrario; Leanne Groban
Journal:  Mol Cell Biochem       Date:  2019-02-02       Impact factor: 3.396

10.  Angiotensin-(1-12)/chymase axis modulates cardiomyocyte L-type calcium currents in rats expressing human angiotensinogen.

Authors:  Santiago Reyes; Che Ping Cheng; Drew J Roberts; Tomohisa Yamashita; Sarfaraz Ahmad; Jessica L VonCannon; Kendra N Wright; Louis J Dell'Italia; Jasmina Varagic; Carlos M Ferrario
Journal:  Int J Cardiol       Date:  2019-10-08       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.